+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Hemophilia Market Research Report by Type, Treatment, Therapy, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 239 Pages
  • October 2022
  • Region: Global
  • 360iResearch™
  • ID: 5532738
UP TO OFF until Dec 31st 2022
The Global Hemophilia Market size was estimated at USD 10.52 billion in 2021, USD 11.69 billion in 2022, and is projected to grow at a CAGR of 11.38% to reach USD 20.09 billion by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Hemophilia to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across Hemophilia A, Hemophilia B, and Hemophilia C.
  • Based on Treatment, the market was studied across On-demand and Prophylaxis.
  • Based on Therapy, the market was studied across Gene therapy, ITI therapy, and Replacement therapy.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Hemophilia market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Hemophilia Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Hemophilia Market, including AMBOSS, AmerisourceBergen Corporation, Baxter International, Inc., Bayer AG, Biogen Idec, Inc., BioMarin Pharmaceutical Inc, CSL Behring LLC, Diapharma Group, F. Hoffmann-La Roche Ltd., FFF Enterprises, Inc., Grifols SA, IQVIA Inc., Kedrion S.p.A, Lineage Medical, Inc., Novo Nordisk A/S, Octopharma AG, Pfizer, Inc., Sanofi-Aventis SA, and Takeda Pharmaceutical Company Limited.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Hemophilia Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Hemophilia Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Hemophilia Market?
4. What is the competitive strategic window for opportunities in the Global Hemophilia Market?
5. What are the technology trends and regulatory frameworks in the Global Hemophilia Market?
6. What is the market share of the leading vendors in the Global Hemophilia Market?
7. What modes and strategic moves are considered suitable for entering the Global Hemophilia Market?
Frequently Asked Questions about the Global Hemophilia Market

What is the estimated value of the Global Hemophilia Market?

The Global Hemophilia Market was estimated to be valued at $10.52 Billion in 2021.

What is the growth rate of the Global Hemophilia Market?

The growth rate of the Global Hemophilia Market is 11.3%, with an estimated value of $20.09 Billion by 2027.

What is the forecasted size of the Global Hemophilia Market?

The Global Hemophilia Market is estimated to be worth $20.09 Billion by 2027.

Who are the key companies in the Global Hemophilia Market?

Key companies in the Global Hemophilia Market include AMBOSS, AmerisourceBergen Corporation, Baxter International, Inc., Bayer AG, Biogen Idec, Inc., BioMarin Pharmaceutical Inc, CSL Behring LLC, Diapharma Group and La Roche Ltd..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of hemophilia across the world
5.1.1.2. Rising promotions and supportive initiatives by government to increase awareness on hemophilia
5.1.1.3. Emerging prevalence of hemophilia in new-borns
5.1.2. Restraints
5.1.2.1. Concerns of adverse side effects and high cost of plasma pertinent products
5.1.3. Opportunities
5.1.3.1. Surge in technologically advanced products and innovations
5.1.3.2. Increasing adoption of prophylaxis treatment
5.1.4. Challenges
5.1.4.1. Strict government regulations and reduced availability of product
5.2. Cumulative Impact of COVID-19
6. Hemophilia Market, by Type
6.1. Introduction
6.2. Hemophilia A
6.3. Hemophilia B
6.4. Hemophilia C
7. Hemophilia Market, by Treatment
7.1. Introduction
7.2. On-demand
7.3. Prophylaxis
8. Hemophilia Market, by Therapy
8.1. Introduction
8.2. Gene therapy
8.3. ITI therapy
8.4. Replacement therapy
9. Americas Hemophilia Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Hemophilia Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Hemophilia Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. AMBOSS
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. AmerisourceBergen Corporation
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Baxter International, Inc.
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Bayer AG
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Biogen Idec, Inc.
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. BioMarin Pharmaceutical Inc
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. CSL Behring LLC
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Diapharma Group
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. F. Hoffmann-La Roche Ltd.
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. FFF Enterprises, Inc.
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Grifols SA
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. IQVIA Inc.
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Kedrion S.p.A
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Lineage Medical, Inc.
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Novo Nordisk A/S
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Octopharma AG
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Pfizer, Inc.
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Sanofi-Aventis SA
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Takeda Pharmaceutical Company Limited
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL HEMOPHILIA MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL HEMOPHILIA MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 4. GLOBAL HEMOPHILIA MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL HEMOPHILIA MARKET SIZE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 6. GLOBAL HEMOPHILIA MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL HEMOPHILIA MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL HEMOPHILIA MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 9. GLOBAL HEMOPHILIA MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL HEMOPHILIA MARKET DYNAMICS
FIGURE 11. GLOBAL HEMOPHILIA MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 12. GLOBAL HEMOPHILIA MARKET SIZE, BY TYPE, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL HEMOPHILIA MARKET COMPETITIVE STRATEGIC WINDOW, BY TYPE, 2027
FIGURE 14. GLOBAL HEMOPHILIA MARKET SIZE, BY HEMOPHILIA A, 2018-2027 (USD BILLION)
FIGURE 15. GLOBAL HEMOPHILIA MARKET SIZE, BY HEMOPHILIA B, 2018-2027 (USD BILLION)
FIGURE 16. GLOBAL HEMOPHILIA MARKET SIZE, BY HEMOPHILIA C, 2018-2027 (USD BILLION)
FIGURE 17. GLOBAL HEMOPHILIA MARKET SIZE, BY TREATMENT, 2021 VS 2027 (%)
FIGURE 18. GLOBAL HEMOPHILIA MARKET SIZE, BY TREATMENT, 2021 VS 2027 (USD BILLION)
FIGURE 19. GLOBAL HEMOPHILIA MARKET COMPETITIVE STRATEGIC WINDOW, BY TREATMENT, 2027
FIGURE 20. GLOBAL HEMOPHILIA MARKET SIZE, BY ON-DEMAND, 2018-2027 (USD BILLION)
FIGURE 21. GLOBAL HEMOPHILIA MARKET SIZE, BY PROPHYLAXIS, 2018-2027 (USD BILLION)
FIGURE 22. GLOBAL HEMOPHILIA MARKET SIZE, BY THERAPY, 2021 VS 2027 (%)
FIGURE 23. GLOBAL HEMOPHILIA MARKET SIZE, BY THERAPY, 2021 VS 2027 (USD BILLION)
FIGURE 24. GLOBAL HEMOPHILIA MARKET COMPETITIVE STRATEGIC WINDOW, BY THERAPY, 2027
FIGURE 25. GLOBAL HEMOPHILIA MARKET SIZE, BY GENE THERAPY, 2018-2027 (USD BILLION)
FIGURE 26. GLOBAL HEMOPHILIA MARKET SIZE, BY ITI THERAPY, 2018-2027 (USD BILLION)
FIGURE 27. GLOBAL HEMOPHILIA MARKET SIZE, BY REPLACEMENT THERAPY, 2018-2027 (USD BILLION)
FIGURE 28. AMERICAS HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 29. AMERICAS HEMOPHILIA MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 30. AMERICAS HEMOPHILIA MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 31. AMERICAS HEMOPHILIA MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 32. ARGENTINA HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 33. BRAZIL HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 34. CANADA HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 35. MEXICO HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 36. UNITED STATES HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 37. UNITED STATES HEMOPHILIA MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 38. UNITED STATES HEMOPHILIA MARKET SIZE, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 39. UNITED STATES HEMOPHILIA MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 40. ASIA-PACIFIC HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 41. ASIA-PACIFIC HEMOPHILIA MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 42. ASIA-PACIFIC HEMOPHILIA MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 43. ASIA-PACIFIC HEMOPHILIA MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 44. AUSTRALIA HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 45. CHINA HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 46. INDIA HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 47. INDONESIA HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 48. JAPAN HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 49. MALAYSIA HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 50. PHILIPPINES HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 51. SINGAPORE HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 52. SOUTH KOREA HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 53. TAIWAN HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 54. THAILAND HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 55. VIETNAM HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 56. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 57. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 58. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 59. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 60. DENMARK HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 61. EGYPT HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 62. FINLAND HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 63. FRANCE HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 64. GERMANY HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 65. ISRAEL HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 66. ITALY HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 67. NETHERLANDS HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 68. NIGERIA HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 69. NORWAY HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 70. POLAND HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 71. QATAR HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 72. RUSSIA HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 73. SAUDI ARABIA HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 74. SOUTH AFRICA HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 75. SPAIN HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 76. SWEDEN HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 77. SWITZERLAND HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 78. TURKEY HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 79. UNITED ARAB EMIRATES HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 80. UNITED KINGDOM HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 81. GLOBAL HEMOPHILIA MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 82. GLOBAL HEMOPHILIA MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 83. GLOBAL HEMOPHILIA MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. GLOBAL HEMOPHILIA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. GLOBAL HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 4. GLOBAL HEMOPHILIA MARKET SIZE, BY REGION, 2018-2027 (USD BILLION)
TABLE 5. GLOBAL HEMOPHILIA MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 6. GLOBAL HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 7. GLOBAL HEMOPHILIA MARKET SIZE, BY HEMOPHILIA A, 2018-2027 (USD BILLION)
TABLE 8. GLOBAL HEMOPHILIA MARKET SIZE, BY HEMOPHILIA A, BY REGION, 2018-2027 (USD BILLION)
TABLE 9. GLOBAL HEMOPHILIA MARKET SIZE, BY HEMOPHILIA A, BY REGION, 2018-2027 (USD BILLION)
TABLE 10. GLOBAL HEMOPHILIA MARKET SIZE, BY HEMOPHILIA B, 2018-2027 (USD BILLION)
TABLE 11. GLOBAL HEMOPHILIA MARKET SIZE, BY HEMOPHILIA B, BY REGION, 2018-2027 (USD BILLION)
TABLE 12. GLOBAL HEMOPHILIA MARKET SIZE, BY HEMOPHILIA B, BY REGION, 2018-2027 (USD BILLION)
TABLE 13. GLOBAL HEMOPHILIA MARKET SIZE, BY HEMOPHILIA C, 2018-2027 (USD BILLION)
TABLE 14. GLOBAL HEMOPHILIA MARKET SIZE, BY HEMOPHILIA C, BY REGION, 2018-2027 (USD BILLION)
TABLE 15. GLOBAL HEMOPHILIA MARKET SIZE, BY HEMOPHILIA C, BY REGION, 2018-2027 (USD BILLION)
TABLE 16. GLOBAL HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 17. GLOBAL HEMOPHILIA MARKET SIZE, BY ON-DEMAND, 2018-2027 (USD BILLION)
TABLE 18. GLOBAL HEMOPHILIA MARKET SIZE, BY ON-DEMAND, BY REGION, 2018-2027 (USD BILLION)
TABLE 19. GLOBAL HEMOPHILIA MARKET SIZE, BY ON-DEMAND, BY REGION, 2018-2027 (USD BILLION)
TABLE 20. GLOBAL HEMOPHILIA MARKET SIZE, BY PROPHYLAXIS, 2018-2027 (USD BILLION)
TABLE 21. GLOBAL HEMOPHILIA MARKET SIZE, BY PROPHYLAXIS, BY REGION, 2018-2027 (USD BILLION)
TABLE 22. GLOBAL HEMOPHILIA MARKET SIZE, BY PROPHYLAXIS, BY REGION, 2018-2027 (USD BILLION)
TABLE 23. GLOBAL HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 24. GLOBAL HEMOPHILIA MARKET SIZE, BY GENE THERAPY, 2018-2027 (USD BILLION)
TABLE 25. GLOBAL HEMOPHILIA MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2027 (USD BILLION)
TABLE 26. GLOBAL HEMOPHILIA MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2027 (USD BILLION)
TABLE 27. GLOBAL HEMOPHILIA MARKET SIZE, BY ITI THERAPY, 2018-2027 (USD BILLION)
TABLE 28. GLOBAL HEMOPHILIA MARKET SIZE, BY ITI THERAPY, BY REGION, 2018-2027 (USD BILLION)
TABLE 29. GLOBAL HEMOPHILIA MARKET SIZE, BY ITI THERAPY, BY REGION, 2018-2027 (USD BILLION)
TABLE 30. GLOBAL HEMOPHILIA MARKET SIZE, BY REPLACEMENT THERAPY, 2018-2027 (USD BILLION)
TABLE 31. GLOBAL HEMOPHILIA MARKET SIZE, BY REPLACEMENT THERAPY, BY REGION, 2018-2027 (USD BILLION)
TABLE 32. GLOBAL HEMOPHILIA MARKET SIZE, BY REPLACEMENT THERAPY, BY REGION, 2018-2027 (USD BILLION)
TABLE 33. AMERICAS HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 34. AMERICAS HEMOPHILIA MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 35. AMERICAS HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 36. AMERICAS HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 37. AMERICAS HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 38. ARGENTINA HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 39. ARGENTINA HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 40. ARGENTINA HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 41. ARGENTINA HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 42. BRAZIL HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 43. BRAZIL HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 44. BRAZIL HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 45. BRAZIL HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 46. CANADA HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 47. CANADA HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 48. CANADA HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 49. CANADA HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 50. MEXICO HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 51. MEXICO HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 52. MEXICO HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 53. MEXICO HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 54. UNITED STATES HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 55. UNITED STATES HEMOPHILIA MARKET SIZE, BY STATE, 2018-2027 (USD BILLION)
TABLE 56. UNITED STATES HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 57. UNITED STATES HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 58. UNITED STATES HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 59. ASIA-PACIFIC HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 60. ASIA-PACIFIC HEMOPHILIA MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 61. ASIA-PACIFIC HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 62. ASIA-PACIFIC HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 63. ASIA-PACIFIC HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 64. AUSTRALIA HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 65. AUSTRALIA HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 66. AUSTRALIA HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 67. AUSTRALIA HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 68. CHINA HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 69. CHINA HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 70. CHINA HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 71. CHINA HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 72. INDIA HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 73. INDIA HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 74. INDIA HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 75. INDIA HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 76. INDONESIA HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 77. INDONESIA HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 78. INDONESIA HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 79. INDONESIA HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 80. JAPAN HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 81. JAPAN HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 82. JAPAN HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 83. JAPAN HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 84. MALAYSIA HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 85. MALAYSIA HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 86. MALAYSIA HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 87. MALAYSIA HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 88. PHILIPPINES HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 89. PHILIPPINES HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 90. PHILIPPINES HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 91. PHILIPPINES HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 92. SINGAPORE HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 93. SINGAPORE HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 94. SINGAPORE HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 95. SINGAPORE HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 96. SOUTH KOREA HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 97. SOUTH KOREA HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 98. SOUTH KOREA HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 99. SOUTH KOREA HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 100. TAIWAN HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 101. TAIWAN HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 102. TAIWAN HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 103. TAIWAN HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 104. THAILAND HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 105. THAILAND HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 106. THAILAND HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 107. THAILAND HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 108. VIETNAM HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 109. VIETNAM HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 110. VIETNAM HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 111. VIETNAM HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 117. DENMARK HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 118. DENMARK HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 119. DENMARK HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 120. DENMARK HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 121. EGYPT HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 122. EGYPT HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 123. EGYPT HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 124. EGYPT HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 125. FINLAND HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 126. FINLAND HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 127. FINLAND HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 128. FINLAND HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 129. FRANCE HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 130. FRANCE HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 131. FRANCE HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 132. FRANCE HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 133. GERMANY HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 134. GERMANY HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 135. GERMANY HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 136. GERMANY HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 137. ISRAEL HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 138. ISRAEL HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 139. ISRAEL HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 140. ISRAEL HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 141. ITALY HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 142. ITALY HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 143. ITALY HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 144. ITALY HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 145. NETHERLANDS HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 146. NETHERLANDS HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 147. NETHERLANDS HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 148. NETHERLANDS HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 149. NIGERIA HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 150. NIGERIA HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 151. NIGERIA HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 152. NIGERIA HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 153. NORWAY HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 154. NORWAY HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 155. NORWAY HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 156. NORWAY HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 157. POLAND HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 158. POLAND HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 159. POLAND HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 160. POLAND HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 161. QATAR HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 162. QATAR HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 163. QATAR HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 164. QATAR HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 165. RUSSIA HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 166. RUSSIA HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 167. RUSSIA HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 168. RUSSIA HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 169. SAUDI ARABIA HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 170. SAUDI ARABIA HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 171. SAUDI ARABIA HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 172. SAUDI ARABIA HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 173. SOUTH AFRICA HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 174. SOUTH AFRICA HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 175. SOUTH AFRICA HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 176. SOUTH AFRICA HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 177. SPAIN HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 178. SPAIN HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 179. SPAIN HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 180. SPAIN HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 181. SWEDEN HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 182. SWEDEN HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 183. SWEDEN HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 184. SWEDEN HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 185. SWITZERLAND HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 186. SWITZERLAND HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 187. SWITZERLAND HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 188. SWITZERLAND HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 189. TURKEY HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 190. TURKEY HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 191. TURKEY HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 192. TURKEY HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 193. UNITED ARAB EMIRATES HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 194. UNITED ARAB EMIRATES HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 195. UNITED ARAB EMIRATES HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 196. UNITED ARAB EMIRATES HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 197. UNITED KINGDOM HEMOPHILIA MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 198. UNITED KINGDOM HEMOPHILIA MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 199. UNITED KINGDOM HEMOPHILIA MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 200. UNITED KINGDOM HEMOPHILIA MARKET SIZE, BY THERAPY, 2018-2027 (USD BILLION)
TABLE 201. GLOBAL HEMOPHILIA MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 202. GLOBAL HEMOPHILIA MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 203. GLOBAL HEMOPHILIA MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 204. GLOBAL HEMOPHILIA MARKET RANKING, BY KEY PLAYER, 2021
TABLE 205. GLOBAL HEMOPHILIA MARKET SHARE, BY KEY PLAYER, 2021
TABLE 206. GLOBAL HEMOPHILIA MARKET MERGER & ACQUISITION
TABLE 207. GLOBAL HEMOPHILIA MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 208. GLOBAL HEMOPHILIA MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 209. GLOBAL HEMOPHILIA MARKET INVESTMENT & FUNDING
TABLE 210. GLOBAL HEMOPHILIA MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 211. GLOBAL HEMOPHILIA MARKET: LICENSE & PRICING

Companies Mentioned

  • AMBOSS
  • AmerisourceBergen Corporation
  • Baxter International, Inc.
  • Bayer AG
  • Biogen Idec, Inc.
  • BioMarin Pharmaceutical Inc
  • CSL Behring LLC
  • Diapharma Group
  • F. Hoffmann-La Roche Ltd.
  • FFF Enterprises, Inc.
  • Grifols SA
  • IQVIA Inc.
  • Kedrion S.p.A
  • Lineage Medical, Inc.
  • Novo Nordisk A/S
  • Octopharma AG
  • Pfizer, Inc.
  • Sanofi-Aventis SA
  • Takeda Pharmaceutical Company Limited

Methodology

Loading
LOADING...